BDX — BCAL Diagnostics Balance Sheet
0.000.00%
Last trade - 00:00- AU$28.91m
- AU$26.77m
- AU$2.65m
Annual balance sheet for BCAL Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3.41 | 9.57 | 3.17 | 6.47 | 4.52 |
| Net Total Receivables | 0.721 | 0.884 | 3.03 | 2.86 | 2.67 |
| Total Current Assets | 4.13 | 10.5 | 6.2 | 9.34 | 7.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.004 | 0.135 | 2.17 | 2.93 | 2.71 |
| Long Term Investments | |||||
| Total Assets | 4.13 | 10.6 | 8.37 | 12.3 | 9.91 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.526 | 0.95 | 2.26 | 2.6 | 3.11 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.526 | 0.95 | 3.16 | 3.68 | 3.69 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3.61 | 9.64 | 5.21 | 8.59 | 6.22 |
| Total Liabilities & Shareholders' Equity | 4.13 | 10.6 | 8.37 | 12.3 | 9.91 |
| Total Common Shares Outstanding |